Document is current

Any future updates will be listed below

Response to McGirr et al.'s Comment on “Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada”

Crossref DOI link: https://doi.org/10.1007/s40121-018-0221-2

Published Online: 2018-11-08

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark